45 related articles for article (PubMed ID: 25860236)
1. Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odyssey.
Hofer KD; Bühler MM; Roncador M; Rechsteiner M; Maggio EM; Tchinda J; Schanz U; Haralambieva E; Widmer CC
Leuk Lymphoma; 2024 Jun; 65(6):808-815. PubMed ID: 38385617
[TBL] [Abstract][Full Text] [Related]
2. Mobile Source Benzene Regulations and Risk of Childhood and Young Adult Hematologic Cancers in Alaska: A Quasi-experimental Study.
Nethery RC; Vega S; Frazier AL; Laden F
Epidemiology; 2023 May; 34(3):385-388. PubMed ID: 36715968
[TBL] [Abstract][Full Text] [Related]
3. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system acute lymphoblastic leukemia: role of natural killer cells.
Frishman-Levy L; Shemesh A; Bar-Sinai A; Ma C; Ni Z; Frenkel S; Muench V; Bruckmueller H; Vokuhl C; Debatin KM; Eckert C; Stanulla M; Schrappe M; Campbell KS; Loewenthal R; Schewe DM; Hochman J; Meyer LH; Kaufman D; Cario G; Porgador A; Izraeli S
Blood; 2015 May; 125(22):3420-31. PubMed ID: 25896649
[TBL] [Abstract][Full Text] [Related]
6. A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine.
Hu M; Li W; Li P; Tan J; Wang Y
Front Oncol; 2024; 14():1329279. PubMed ID: 38737911
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry.
Sadowska-Klasa A; Zaucha JM; Labopin M; Bourhis JH; Blaise D; Yakoub-Agha I; Salmenniemi U; Passweg J; Fegueux N; Schroeder T; Giebel S; Brissot E; Ciceri F; Mohty M
Bone Marrow Transplant; 2024 Mar; 59(3):387-394. PubMed ID: 38195982
[TBL] [Abstract][Full Text] [Related]
8. Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
Parrondo RD; Rahman ZA; Heckman MG; Wieczorek M; Jiang L; Alkhateeb HB; Litzow MR; Greipp P; Sher T; Bergsagel L; Fonseca R; Roy V; Dispenzieri A; Kharfan-Dabaja MA; Murthy HS; Ailawadhi S; Foran JM
Blood Cancer J; 2022 Jun; 12(6):87. PubMed ID: 35650175
[No Abstract] [Full Text] [Related]
9. Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia.
Vasudevan Nampoothiri R; Viswabandya A
Indian J Hematol Blood Transfus; 2021 Oct; 37(4):521-527. PubMed ID: 34744336
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia.
Abdel Rahman ZH; Parrondo RD; Heckman MG; Wieczorek M; Miller KC; Alkhateeb H; Sproat LZ; Murthy H; Hogan WJ; Kharfan-Dabaja MA; Peterson JF; Baughn LB; Hoppman N; Litzow MR; Ketterling RP; Greipp PT; Foran JM
Br J Haematol; 2022 Feb; 196(4):963-968. PubMed ID: 34697797
[TBL] [Abstract][Full Text] [Related]
11. Common B-cell acute lymphoblastic leukaemia in a 70-year-old woman presenting 2 years after carboplatin-taxane radiotherapy for endometrial cancer.
Murray NP; Orrego S; López MA; Munoz L; Minzer S
Ecancermedicalscience; 2019; 13():972. PubMed ID: 31921343
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
Saygin C; Kishtagari A; Cassaday RD; Reizine N; Yurkiewicz I; Liedtke M; Stock W; Larson RA; Levine RL; Tallman MS; Park JH; Kerr C; Przychodzen B; Sekeres MA; Kalaycio ME; Carraway HE; Hamilton BK; Sobecks R; Gerds A; Mukherjee S; Nazha A; Maciejewski JP; Advani AS
Blood Adv; 2019 Dec; 3(24):4228-4237. PubMed ID: 31869410
[TBL] [Abstract][Full Text] [Related]
13. Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.
Jabagi MJ; Goncalves A; Vey N; Le Tri T; Zureik M; Dray-Spira R
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569513
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related acute lymphoblastic leukemia.
Ribera JM
Haematologica; 2018 Oct; 103(10):1581-1583. PubMed ID: 30270204
[No Abstract] [Full Text] [Related]
15. Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy.
Kelleher N; Gallardo D; González-Campos J; Hernández-Rivas JM; Montesinos P; Sarrá J; Gil C; Barba P; Guàrdia R; Brunet S; Bernal T; Martínez MP; Abella E; Bermúdez A; Sánchez-Delgado M; Antònia C; Gayoso J; Calbacho M; Ribera JM;
Leuk Lymphoma; 2016; 57(1):86-91. PubMed ID: 25860236
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
[TBL] [Abstract][Full Text] [Related]
17. Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?
Pagano L; Pulsoni A; Tosti ME; Mele A; Mele L; Corvatta L; Miraglia E; Almici C; Manna A; Del Poeta G; Lanza F; Masini L; Recchia A; Equitani F; Leone G; Mandelli F;
Hematol J; 2000; 1(5):329-32. PubMed ID: 11920210
[TBL] [Abstract][Full Text] [Related]
18. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance.
Rosenberg AS; Brunson A; Paulus JK; Tuscano J; Wun T; Keegan THM; Jonas BA
Blood Cancer J; 2017 Sep; 7(9):e605. PubMed ID: 28885611
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
